Subarachnoid Hemorrhage clinical trials

Explore recruiting subarachnoid hemorrhage clinical trials.

Recruiting subarachnoid hemorrhage studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Subarachnoid Hemorrhage trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Complement Inhibition: Attacking the Overshooting Inflammation @fter Subarachnoid Hemorrhage - A phase II trial on the safety and efficacy of C1 esterase inhibitor for the acute management of subarachnoid hemorrhage

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Efficacy of daily IV administration of dornase alfa for up to 14 days post subarachnoid haemorrhage on functional independence at 6 months: a multicentre open-label randomised controlled trial of the PROBE type Probe

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Stereotactic Cisternal Lavage Therapy in Patients with Aneurysmal Subarachnoid Hemorrhage with Urokinase and Nimodipine for the Prevention of Secondary Brain Injury. A Randomized Controlled Trial - SPLASH

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

MIVAR - Milrinone Infusion for VAsospam treatment in subarachnoid hemoRrhage

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Evaluation of the efficacy of sphenopalatine block in headache in patients with non-traumatic subarachnoid hemorrhage (SAH) after training of neurosurgical intensive care nurses.

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Deferoxamine in Aneurysmal Subarachnoid Hemorrhage trial (DASH)

Netherlands

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Subarachnoid Hemorrhage trials by city

Subarachnoid Hemorrhage in Toronto Subarachnoid Hemorrhage in Vancouver Subarachnoid Hemorrhage in Montreal Subarachnoid Hemorrhage in Calgary Subarachnoid Hemorrhage in Edmonton Subarachnoid Hemorrhage in Ottawa Subarachnoid Hemorrhage in Winnipeg Subarachnoid Hemorrhage in Quebec City Subarachnoid Hemorrhage in Hamilton Subarachnoid Hemorrhage in Kitchener Subarachnoid Hemorrhage in London Subarachnoid Hemorrhage in Halifax Subarachnoid Hemorrhage in New York Subarachnoid Hemorrhage in Los Angeles Subarachnoid Hemorrhage in Chicago Subarachnoid Hemorrhage in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease